Figure S1, Figure S2, Table S1 from Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors
Authors:
- Maria GrigoriouMGMaria Grigoriou
- Aggelos BanosABAggelos Banos
- Aikaterini HatzioannouAHAikaterini Hatzioannou
- Andreas KloetgenAKAndreas Kloetgen
- Panagiotis KouzisPKPanagiotis Kouzis
- Despoina AggourakiDADespoina Aggouraki
- Roubini ZakopoulouRZRoubini Zakopoulou
- Giorgos BamiasGBGiorgos Bamias
- Eva KassiEKEva Kassi
- Dimitrios MavroudisDMDimitrios Mavroudis
- Aristotelis BamiasAristotelis Bamias
- Dimitrios T. BoumpasDBDimitrios T. Boumpas
Open Access
- 4 April 2023
- other
- Published by American Association for Cancer Research (AACR)